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Plasma cells produce relatively large amounts  of immunoglobulin  compared to 
other cell proteins.  While  little  is known  about the  mechanism  responsible for 
this  apparent  selective amplification  of immunoglobulin  synthesis,  it must act 
independently  on the production  of heavy and  light chains since the structural 
genes for the two polypeptide chains are not linked genetically (1) and the chains 
are translated  from separate messengers (2). On the other hand,  the synthesis of 
the  two polypeptide  chains  is  relatively well coordinated  since  most myeloma 
tumors and normal lymph node cells synthesize either a moderate excess of light 
chains or equimolar amounts of heavy and light chains  (3-5). 
The  synthesis  of light  chains  can  obviously occur  in  the  absence  of heavy 
chains since many mouse and human myelomas produce only light chains (6, 7). 
However, it is possible that the loss of heavy-chain synthesis might affect the rate 
of light-chain  synthesis. In order to examine this possibility, we have determined 
the amounts of light and heavy chains synthesized by two independent MPC-11 
mouse myeloma cell lines,  and  by light-chain-producing  variants  derived from 
each of these cell lines. 
Materials  and Methods 
The adaptation of the MPC-11 IgG2b-producing mouse myeloma tumor to continuous culture has 
been described previously (8). Line I was derived from a spleen clone of the original tumor, while line 
II was adapted directly from the MPC-11  tumor (8).  These lines were maintained in suspension 
culture either in Petri dishes (Falcon Plastics, Div. of BioQuest, Oxnard, Calif.) or spinner bottles by 
feeding with Dulbecco's medium (Grand Island Biological Co., Grand Island, N. Y.) supplemented 
with 20% inactivated horse serum, nonessential amino acids, and glutamine (8). The myeloma cells 
were cloned in soft agar as described previously (9, 10). Variants which had lost the ability to produce 
heavy (H)  chains were identified and enumerated by "staining" the clones directly on agar plates 
with specific anti-H-chain antiserum (9,  10). 
The doubling time of the cells was calculated from a growth curve. Cells were diluted into fresh 
medium  and  the  cell  counts  were  made  at  frequent  intervals  in  a  Coulter  Counter  (Coulter 
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Electronics,  Inc.,  Fine Particle  Group,  Hialeah,  Fla.). Total  cell  protein was  determined by  a 
modification of  the  method  of  Lowry (11), using crystalline bovine serum  albumin (Armour 
Pharmaceutical Co., Chicago,  Ill.)  as a  standard. Chromosomes  were analyzed according  to the 
method of Bunker (12). 
The  pattern  of  immunoglobulin production  was  then  determined  by  incubating cells  with 
radioactive  amino  acids,  making cytoplasmic  extracts  with  the  detergent  Nonidet P-40  (13), 
specifically precipitating the intracellular immunoglobulins  using indirect immunological  precipita- 
tion (14), and then analyzing the dissolved immune precipitate in sodium dodecyl sulfate (SDS) 
containing acrylamide gels (8). To determine the ratio of light (L) and H chains, the cytoplasmic 
immune precipitates were  reduced  and  alkylated and  then  electrophoresed  on SDS-containing 
acrylamide gels (8). 
In order  to determine the relative and absolute amount of gamma globulin synthesized,  serial 
dilutions of cytoplasm derived from cells labeled for 30 rain were added to 0.20-ml portions of the 
rabbit antimouse IgG  antiserum. The  reaction mixtures were incubated at  4~C  for  24  h.  The 
precipitates were washed and dissolved as described  above and duplicate 10h samples were taken 
from  the  immune precipitates and the  supernate and precipitated with  12.5% TCA. The TCA- 
precipitated material was collected on millipore filters,  washed,  and counted in a low background 
counter (Nuclear-Chicago  Corp., Des Plaines, Ill.). By examining dilutions of a given cytoplasm,  we 
were  actually carrying out a  quantitative precipitin curve  and could  therefore  be sure  that the 
determination was carried  out in the presence of excess antibody (14}. Controls for the nonspecific 
precipitation of radioactive material were carried out by adding rabbit anti-h bacteriophage  serum to 
the cytoplasmic  extract together  with sheep antirabbit gamma globulin. No more than 1.5% of the 
acid  precipitable radioactivity was  precipitated nonspecifically.  The relative amount of labeled 
gamma globulin present in the myeloma cells was calculated by subtracting the amount of acid 
precipitable radioactivity in the nonspecific precipitate of the cytoplasm  from that in the specific 
precipitate and then dividing  by the total amount of TC A precipitable radioactivity in the whole cell. 
The relative rate of synthesis of the individual H and L chains was calculated using a ratio of 
radioactivity in H/L chains of 3/1. This was determined by reducing purified labeled IgG (H2L2) and 
determining the ratio of radioactivity. This 3/1 ratio is higher than that expected from the relative 
molecular weights of H and L chains and is due to preferential  labeling of H chains by the valine, 
threonine, and leucine mixture, since the H/L ratio of radioactivity in H~L2 labeled with mixed amino 
acids is the expected  2.3/1. 
The absolute amount of immunoglobulin  synthesized per  cell was calculated according to the 
formula A = (R × P)/D where: A = the absolute amount of immunoglobulin  synthesized expressed as 
picogram per cell per hour; R = the relative amount of immunoglobulin  synthesized (i.e., percent of 
total TCA precipitable radioactivity); P  = protein content (picogram per cell) of the myeloma cells; 
and D  =  doubling time  (hour)  of the  cell  population in culture. The  amount of intracellular 
immunoglobulin  was determined by radial immunodiffusion  in agar (15) using purified preparation of 
MPC-11 myeloma protein to construct a calibration curve. 
Results 
The relative amount of immunoglobulin produced by clones obtained from two 
independently  adapted  MPC-11  cell  lines  are  presented  in Table  I.  Approxi- 
mately 16% of the protein synthesized by line I and 25% of the protein produced 
by line II was gamma globulin. The molar ratio of L/H chains produced in both 
cell lines was  approximately 2/1.  Since both cell  lines could generate variants 
producing  only  L  chains  (16),  the  number  of  such  variants  was  monitored 
throughout these experiments. The contamination of line I increased to between 
11  and  15%  for  different subclones, while  the  contamination of line II did not 
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explain the apparent differences in the amounts of H and L chains synthesized by 
the two cell lines. 
When variants producing only L chains were isolated from each cell line, they 
made the same relative amount of L chains as the parent H plus L chain producer 
(Table I). The absolute rate of H- and L-chain syntheis was also determined for 
lines  I  and  II,  and  a  L-chain  producer  derived  from  line  II  (II-L)  (Table II). 
Although  each  of  the  numbers  used  in  this  calculation  (see  Materials  and 
Methods)  is subject to appreciable error,  the results were consistent with those 
presented in Table I. The absolute size of the intracellular pool of immunoglobu- 
lin  was also determined  for lines I  and  II using radial  immunodiffusion.  Cells 
from  line  I  contained  approximately  3.5  pg/cell  while  line  II  cells  contained 
approximately 6.0 pg/cell, indicating that the pool size reflected the relative rates 
of synthesis of immunoglobulin  by the two cell lines. 
TABLE | 
Relative Rate of Gamma Globulin Synthesis 
Radioactivity specifically 
Cell line  Polypeptides  precipitated  Molar ratio 
produced  L/H 
Total  H  L 
%  %  % 
Cell line I  H,L  16.1  9.7  6.4  2.0 
L  5.3  5.3 
Cell line II  H,L  25.2  15.8  9.4  1.8 
L  9.0  9.0 
Each of the determinations represents the average of 2-4 independent experi- 
ments. The difference between experiments was less than 10%. 
Discussion 
The rate of production of immunoglobulin  by these cell lines was comparable to 
that reported by Nathans et al.  (17) and Humphrey and Fahey (18) for a mouse 
myeloma tumor in vivo. These authors found that 14-19 mg of myeloma protein 
was produced by each gram of tumor per day, which is equivalent to a production 
of  approximately  30-50  pg/cell/24  h.  Nossal  and  Makela  estimated  that 
suspensions of lymphoid cells in vitro also produced similar amounts of antibody 
(19).  A  human  myeloma  cell  line  produced  18  pg  of L  chains/cell/day  (20). 
Various human lymphoblastic lines have been shown to produce smaller amounts 
of immunoglobulin  (21). The size of the intracellular pool of gamma globulin has 
been  measured  in  only a  few studies.  Berenbaum  (22)  estimated  that  normal 
lymphoid  cells  contain  0.75  pg/cell,  while  Salmon  and  Smith  (23)  found  the 
myeloma  cells  contained  1.5  pg/cell.  Gitlin  and  Sasaki  (24)  examined  the 
immunoglobulin content of human tonsilar lymphoid cells and found between 0.2 
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TABLE II 
Absolute Amount of Immunoglobulin Synthesized 
1115 
-globulin 
Cell line  synthesized  H chains synthesized  L chains synthesized 
pg/cell/h  pg/cell/h  molecule/ceU/min  pg/ceU/h  molecule/cell/min 
I  2.5  1.5  280,000  1.0  455,000 
II  3.6  2.12  400,000  1.33  605,000 
II-L  1.2  1.2  540,000 
The amount of immunoglobulin synthesized by each of these cell lines was calculated as described in 
the Materials and Methods. The doubling time of line I was 22.1 h and its ceils contained 346 =~ 39 
pg/cell. Line II doubled every 20.3 h and contained 327 ± 28 pg/cell. Line II-L doubled every 24.6 h 
and contained 327 ± 71 pg/cell. 
The  studies  reported  here  do not  provide any  explanation  for the  different 
amounts  of immunoglobulin  produced by the two cell lines studied.  Both cell 
lines had a heteroploid modal chromosome number of 65, but detailed karyotypic 
analysis  of mouse  chromosomes  is  not  possible  without  special  staining  tech- 
niques. The two cell lines may represent different populations which were present 
in the tumor at the time it was adapted to culture, or they may represent variants 
which arose during the adaptation to culture. 
Both  cell  lines  produced  excess L  chains.  However,  the  L-chain-producing 
variants derived from lines I and II continued to produce approximately the same 
amount  of L  chains  as  their  respective  parent  cells.  This  indicates  that  the 
amount of L chains produced was not dependent upon the continued synthesis of 
H  chains. 
Summary 
The rates of immunoglobulin synthesis have been examined in two MPC-11 cell 
lines which were independently adapted to tissue culture and in light-chain-pro- 
ducing  variants  derived  from  each  of them.  One  cell  line  synthesized  2.5  pg 
immunoglobulin/cell/h,  while  the  other  synthesized  3.6  pg  immunoglobulin/ 
cell/h. The ratio of heavy and light chains in the two cell lines was approximately 
the  same,  and  the  size  of  the  intracellular  pool  of  immunoglobulin  was 
proportioned to the rate of synthesis. Variants which had spontaneously lost the 
ability  to  produce  heavy  chains  continued  to  synthesize  light  chains  at 
approximately the same rate as their parent cell line. 
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